NXGL
NXGL
NASDAQ · Health Care

Nexgel Inc

$4.24
+0.66 (+18.44%)
Financial Highlights (FY 2026)
Revenue
4.47M
Net Income
-1,173,650
Gross Margin
39.5%
Profit Margin
-26.3%
Rev Growth
+77.3%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.47M 2.52M 5.33M 4.69M
Gross Profit 1.76M 994.9K 3.32M 2.92M
Operating Income -1,247,787 -633,465 798.7K 735.9K
Net Income -1,173,650 -595,828 604.4K 705.4K
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Rev Growth +77.3% +77.3% +6.5% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 924.4K 924.4K 6.23M 5.69M
Total Equity 4.61M 4.61M 8.36M 7.17M
D/E Ratio 0.20 0.20 0.75 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -958,276 -513,516 1.03M 893.3K
Free Cash Flow — — 660.3K 478.5K